TABLE 1.
Characteristics of patients in low- and high-risk scores in TGGA cohort.
| Characteristic | High, N = 228 a | Low, N = 228 a |
|---|---|---|
| Age | 60 (51, 71) | 56 (45, 68) |
| Gender | ||
| Female | 90 (39%) | 82 (36%) |
| Male | 138 (61%) | 146 (64%) |
| Bmi | 26.1 (23.0, 30.2) | 28.0 (24.9, 33.3) |
| Unknown | 97 | 121 |
| M.stage | ||
| M0 | 206 (95%) | 200 (93%) |
| M1 | 10 (4.6%) | 14 (6.5%) |
| Unknown | 12 | 14 |
| N.stage | ||
| N0 | 117 (53%) | 109 (50%) |
| N1 | 31 (14%) | 42 (19.8%) |
| N2 | 23 (10.4%) | 25 (11.6%) |
| N3 | 29 (13%) | 27 (12%) |
| NX | 21 (9.5%) | 13 (6.0%) |
| Unknown | 7 | 12 |
| T.stage | ||
| T0 | 6 (2.8%) | 17 (8.1%) |
| T1 | 13 (5.9%) | 27 (12.8%) |
| T2 | 37 (17%) | 40 (19%) |
| T3 | 42 (19.3%) | 48 (22.8%) |
| T4 | 97 (44%) | 51 (24.1%) |
| Tis | 6 (2.8%) | 1 (0.5%) |
| TX | 17 (7.8%) | 27 (13%) |
| Unknown | 10 | 17 |
| TCGA_subtype | ||
| - | 12 (7.6%) | 6 (3.6%) |
| BRAF_Hotspot_Mutants | 58 (37%) | 88 (53%) |
| NF1_Any_Mutants | 13 (8.2%) | 12 (7.3%) |
| RAS_Hotspot_Mutants | 47 (30%) | 44 (27%) |
| Triple_WT | 28 (18%) | 15 (9.1%) |
| Unknown | 70 | 63 |
| Sample_type | ||
| Additional Metastatic | 1 (0.4%) | 0 (0%) |
| Metastatic | 151 (66%) | 206 (90%) |
| Primary Tumor | 76 (33%) | 22 (9.6%) |
| Braf | ||
| False | 112 (49%) | 83 (36%) |
| True | 116 (51%) | 145 (64%) |
a
Median (IQR); n (%).